American Research & Management Company’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 374 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 374 |
|
|
2022
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 373 |
|
|
2021
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 360 |
|
|
2021
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 352 |
|
|
2021
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 359 |
|
|
2021
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 339 |
|
|
2020
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 322 |
|
|
2020
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 303 |
|
|
2020
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 290 |
|
|
2020
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 283 |
|
|
2019
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 299 |
|
|
2019
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 303 |
|
|
2019
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 323 |
|
|
2019
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 356 |
|
|
2018
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 316 |
|
|
2018
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 327 |
|
|
2018
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 310 |
|
|
2018
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 346 |
|
|
2017
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 344 |
|
|
2017
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 309 |
|
|
2017
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 311 |
|
|
2017
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 302 |
|
|
2016
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 319 |
|
|
2016
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 330 |
|
|
2016
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 315 |
|
|
2016
Q1 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 327 |
|